60+ eminent doctors put their name and their institutions behind it and did not have to do that. It’s not BS as much as that comment suggests some might like it to be.
Yes, if bought out, we get an immediate substantial price and often companies with new products settle in a range for a while before they rocket further, nothing unusual or bad about that. They also can often be given a value based upon their potential, even absent revenues. It just depends on a variety of market circumstances and conditions. The reality is, if approved, DCVax has incredible potential value and everyone will know it regardless.